Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects

1. Genebat, M.
2. Vera, F.
3. Hernández-Quero, J.
4. Domingo, P.
5. Guardiola, J.M.
6. Martínez-Madrid, O.
7. Martínez, L.
8. De La Llana, F.G.
9. Sánchez-Villegas, J.
10. Álvarez, H.
11. Mariño, A.
12. Lluch, J.F.
13. Martínez-Pérez, M.A.
14. Marín, J.
15. Ruiz-Mateos, E.
16. Leal, M.